What You Should Know:
- Pear Therapeutics today announced that it has
successfully closed an $80 million Series D financing led by SoftBank Vision
Fund 2.
- Pear is the
leader in prescription digital therapeutics and the first company to receive
FDA authorization for a prescription digital therapeutic (PDT) to treat
disease.
- Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
M&A: Ro Acquires On-Demand, In-Home Platform Workpath
What You Should Know:
- Ro announced it has acquired Workpath, a technology
platform that powers on-demand, in-home healthcare and diagnostics services
nationwide.
- Through this acquisition, Ro’s platform will now
uniquely bring together a patient's doctor, pharmacy, and
diagnostics/lab--offering a personalized, end-to-end experience with no
insurance required.
- Ro is also announcing a partnership with Quest
Diagnostics, which operates more than 2,200 locations nationwide, to
Read More
Medical AI Startup SegMed Nabs $2M to Aggregate Medical Data for Research
What You Should Know:
- Segmed emerges out of stealth and has
secured $2M in seed funding to empower medical AI efforts through easy access
to high-quality, structured and anonymized training data sets.
- The healthcare industry is amassing data at an unprecedented rate but unless this data is standardized, labeled, and curated for use by patients and clinicians, it is not beneficial.
- Segmed simplifies the process by
enabling AI developers to achieve faster development times,
Read More
Backed by Redesign Health, MedArrive Launches with $4.5M in Funding for Care Management Platform
What You Should Know:
- With $4.5 million in funding from
Kleiner Perkins and Define Ventures, and backed by Redesign Health, MedArrive
is poised to bridge the virtual care gap and make affordable at-home care the
new norm.
- Co-founded by the former head of Uber Health, MedArrive enables healthcare providers to seamlessly extend care services into the home, unlocking access to high-quality healthcare for more people at a fraction of the cost.
- MedArrive’s fully integrated care
Read More
Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform
What You Should Know:
- Biopharma startup Rubedo Life Sciences raises $12M to develop a broad portfolio of innovative therapies engineered to target cells for chronic age-related diseases.
- Rubedo’s proprietary ALEMBIC™ drug discovery platform, has generated a novel pipeline of therapeutic candidates that selectively target senescent cells, pro-inflammatory and pro-fibrotic cell populations that result from a variety of cellular stress and damage.
Rubedo Life Sciences, a
Read More
Everlywell Secures $175M to Expand Position in At-Home Testing Market
What You Should Know:
- Everlywell secures $175M in Series D funding to expand
its virtual care offerings, scale its testing and infrastructure, drive
clinical research and disease management through testing, and grow its national
leadership position in the at-home testing market.
- Since launching in 2016, more than one million people have used Everlywell's tests and digital platform to manage their health and wellness. As more people turn toward digital platforms for their health
Read More
Israeli Digital Health VC Firm OTV Closes $170M Venture Fund
What You Should Know:
- OTV (formerly Olive Tree
Ventures), Israel’s ‘digital health first’ venture capital firm closes $170
million venture fund to support innovative digital health companies worldwide.
- OTV also announced today a new China
office and the appointment of Jose Antonio Urrutia Rivas as Head of Asia
Pacific.
OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of
Read More
London-Based uMed Secures $4.8M to Automate & Advance Clinical Research Registries
What You Should Know:
- London-based uMed has raised nearly $4.8m in venture
capital funding to help healthcare providers in the UK and US participate in
more clinical studies.
- The funding will enable uMed to grow its innovative platform which automates processes in running clinical research registries while ensuring regulatory compliance. Its platform can link some of the richest sources of healthcare data and drive a step-change in how clinical and real-world research is
Read More
Virta Health Reaches Unicorn Status After Raising $65M to Reverse Type 2 Diabetes
What You Should Know:
- Virta just
closed a $65 Series D round, to scale its virtual clinic and approach to
reversing chronic metabolic conditions (T2D, prediabetes, and obesity) to the
masses.
- The financing, led by Sequoia Capital Global Equities,
also hurdles Virta well into unicorn territory ($1.1B+ valuation), recognizing
pre-pandemic growth that has accelerated during the COVID era.
Virta Health, a
San Francisco, CA-based company delivering the first
Read More
Olive Hits $1.5B Valuation with Additional $225.5M Funding for AI-Powered Digital Employee Platform
What You Should Know:
- AI workforce management for healthcare provider Olive lands an additional $225.5M in funding, bringing the company’s valuation to $1.5B.
- This latest funding round will enable
Olive to accelerate product development, and the company plans to announce more
capabilities in 2021 to support the entire healthcare ecosystem.
Olive,
the company creating the AI workforce for healthcare, today
announced an additional $225.5M in financing led by Tiger Global
Read More
